Silvant Capital Management »

Bridgebio Pharma shares owned by Silvant Capital Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Silvant Capital Management from 13F filings

Historical chart of Silvant Capital Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Silvant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Silvant Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $28k 378 74.48
2021-12-31 $43k 2.6k 16.66
2021-09-30 $129k 2.7k 46.98
2021-06-30 $167k 2.7k 60.82
2021-03-31 $169k 2.7k 61.54

More positions owned by Silvant Capital Management

NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Apple (AAPL)
Ge Vernova (GEV)
Ge Aerospace Com New (GE)
Meta Platforms Cl A (META)
Royal Caribbean Cruises (RCL)
Visa Com Cl A (V)
Arm Holdings Sponsored Ads (ARM)
Amazon (AMZN)
Teradyne (TER)
Netflix (NFLX)

View all positions for Silvant Capital Management

Top funds holding Bridgebio Pharma

Jupiter Topco
Kohlberg Kravis Roberts & Co
Henderson Group
Farallon Capital Management
BlackRock
Viking Global Investors
Vanguard Capital Management
Vanguard Portfolio Management
Jane Street
UBS Group
Wellington Management Company
State Street Corporation
Two Sigma Investments
Aisling Capital Management
Citadel Advisors

View all funds holding Bridgebio Pharma